Sutro Biopharma, Inc. (STRO)
USD 0.98
(8.53%)
USD 0.98
(8.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 153.73 Million | 67.77 Million | 61.88 Million | 42.72 Million | 42.73 Million | 38.41 Million |
| Cost of Revenue | 180.42 Million | 8.28 Million | 9.77 Million | 76.96 Million | 65.61 Million | 54.26 Million |
| Gross Profit | -26.69 Million | 59.48 Million | 52.1 Million | -34.23 Million | -22.87 Million | -15.84 Million |
| Operating Expenses | 243 Million | 196.71 Million | 160.4 Million | 113.77 Million | 98.2 Million | 75.64 Million |
| Selling, General and Administrative Expenses | 62.58 Million | 59.54 Million | 56 Million | 36.81 Million | 32.59 Million | 21.38 Million |
| Research and Development Expenses | 180.42 Million | 137.17 Million | 104.4 Million | 76.96 Million | 65.61 Million | 54.26 Million |
| Other Expenses | - | - | - | - | -4.35 Million | 1.91 Million |
| Cost and Expenses | 243 Million | 196.71 Million | 160.4 Million | 113.77 Million | 98.2 Million | 75.64 Million |
| Operating Income | -89.27 Million | -128.94 Million | -98.52 Million | -71.05 Million | -55.46 Million | -37.22 Million |
| Interest Expense | 23.75 Million | 3.34 Million | 3.13 Million | 4.07 Million | 4.35 Million | 1.62 Million |
| Income Tax Expense | 18.19 Million | 2.5 Million | 3.13 Million | 4.07 Million | 8.67 Million | 3.52 Million |
| Earnings before Tax | -88.6 Million | -116.7 Million | -105.53 Million | -32.12 Million | -55.74 Million | -35.31 Million |
| Net Income | -106.79 Million | -119.2 Million | -108.67 Million | -36.2 Million | -55.74 Million | -35.31 Million |
| Earnings Per Share Basic | -1.78 | -2.35 | -2.36 | -1.11 | -2.43 | -6.13 |
| Earnings Per Share Diluted | -1.78 | -2.35 | -2.36 | -1.11 | -2.43 | -6.13 |
| Weighted Average Shares Outstanding | 60.16 Million | 50.73 Million | 46.11 Million | 32.57 Million | 22.95 Million | 5.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 60.16 Million | 50.73 Million | 46.11 Million | 32.57 Million | 22.95 Million | 5.75 Million |
| Gross Margin | -0.17 | 0.88 | 0.84 | -0.80 | -0.54 | -0.41 |
| EBIT Margin | -0.44 | -1.85 | -1.50 | -1.53 | -1.09 | -0.76 |
| Profit Margin | -0.69 | -1.76 | -1.76 | -0.85 | -1.30 | -0.92 |
| EBITDA | -67.91 Million | -105.07 Million | -98.52 Million | -23.75 Million | -46.61 Million | -32.81 Million |
| Earnings Before Tax Margin | -0.58 | -1.90 | -1.59 | -1.66 | -1.30 | -0.97 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 25.7 Million | 13 Million | 113.72 Million | 153.73 Million | 16.92 Million | 10.41 Million |
| Cost of Revenue | 1.79 Million | 1.76 Million | 1.73 Million | 6.81 Million | 1.73 Million | 2.39 Million |
| Gross Profit | 23.91 Million | 11.24 Million | 111.99 Million | 146.91 Million | 15.18 Million | 8.01 Million |
| Operating Expenses | 74.39 Million | 67.83 Million | 68.83 Million | 236.19 Million | 60.93 Million | 56.59 Million |
| Selling, General and Administrative Expenses | 12.37 Million | 10.96 Million | 15.07 Million | - | 15.26 Million | 14.99 Million |
| Research and Development Expenses | 62.02 Million | 56.87 Million | 53.76 Million | - | 45.66 Million | 41.59 Million |
| Other Expenses | -62.02 Million | - | - | - | - | - |
| Cost and Expenses | 74.39 Million | 69.59 Million | 70.56 Million | 243 Million | 60.93 Million | 56.59 Million |
| Operating Income | -48.68 Million | -56.59 Million | 43.15 Million | -89.27 Million | -44.01 Million | -46.17 Million |
| Interest Expense | -7.28 Million | 9.39 Million | 8.73 Million | 23.75 Million | -5.93 Million | 3.35 Million |
| Income Tax Expense | 8000.00 | 1.71 Million | 15.8 Million | 18.19 Million | 1.83 Million | 151 Thousand |
| Earnings before Tax | -48.01 Million | -58.21 Million | 46.87 Million | -88.6 Million | -47.44 Million | -38.37 Million |
| Net Income | -48.01 Million | -58.21 Million | 31.06 Million | -106.79 Million | -49.28 Million | -38.52 Million |
| Earnings Per Share Basic | -0.59 | -0.95 | 0.51 | - | -0.81 | -0.64 |
| Earnings Per Share Diluted | -0.59 | -0.95 | 0.51 | - | -0.81 | -0.64 |
| Weighted Average Shares Outstanding | 81.22 Million | 61.45 Million | 61 Million | 60.16 Million | 60.59 Million | 60.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 81.22 Million | 61.45 Million | 61 Million | 60.16 Million | 60.59 Million | 60.33 Million |
| Gross Margin | 0.93 | 0.86 | 0.98 | 0.96 | 0.90 | 0.77 |
| EBIT Margin | -1.89 | -4.22 | 0.39 | - | -2.60 | -4.00 |
| Profit Margin | -1.87 | -4.48 | 0.27 | -0.69 | -2.91 | -3.70 |
| EBITDA | -48.68 Million | -54.83 Million | 44.88 Million | - | -44.01 Million | -41.6 Million |
| Earnings Before Tax Margin | -1.89 | -4.35 | 0.38 | -0.58 | -2.60 | -4.44 |
ALUA
CHOICEIN
PUSOF
301011
9039
1259